Disease | eclampsia |
Comorbidity | C0020538|hypertension |
Sentences | 22 |
PubMedID- 24747797 | Objectives: some women with isolated gestational proteinuria (igp) later develop hypertension and are diagnosed with pre-eclampsia (pe). |
PubMedID- 26471339 | The hypertension associated with pre-eclampsia develops during pregnancy and remits after delivery, suggesting that the placenta is the most likely origin of this disease. |
PubMedID- 20426852 | hypertension with proteinuria (pre-eclampsia) was significantly increased in the preterm group. |
PubMedID- 22727414 | Risk factors for eclampsia among patients with pregnancy-related hypertension at maroua regional hospital, cameroon. |
PubMedID- 22703533 | Current hypertension and a history of early-onset pre-eclampsia (<37 weeks) were independently associated with the presence of wmls (beta = 1.34, p = 0.02 and beta = 1.73, p = 0.01, respectively). |
PubMedID- 22669215 | Pres can be caused by various heterogeneous factors, such as hypertension, side effect of drug therapies, eclampsia, sepsis or autoimmune diseases. |
PubMedID- 21298203 | Guidelines for the treatment of hypertension associated with severe pre-eclampsia and eclampsia are provided by the national health department. |
PubMedID- 25571960 | Se-treated women who took < 60 % of their treatment pills; for explanation see the experimental methods section), treatment (se v. placebo) became significant (or 0·297, 95 % ci 0·089, 0·995, p= 0·049) (adjusted model 2; table 3).table 3unadjusted and adjusted risk factors for the development of pre-eclampsia (pe)/pregnancy-induced hypertension (pih) determined by logistic regression (odds ratios and 95 % confidence intervals).unadjusted model*adjusted model 1†adjusted model 2‡risk factorswomen (n)or95 % cipwomen (n)adjusted or95 % cipwomen (n)adjusted or95 % cipbaseline diastolic bp2271·141·07, 1·21< 0·00052171·101·03, 1·180·0052101·121·04, 1·200·002bmi (kg/m2)2271·201·09, 1·32< 0·00052171·131·00, 1·270·0492101·080·96, 1·220·214toenail se, 16 weeks (μg/g)∥2170·340·164, 0·720·0052170·380·17, 0·870·0212100·320·13, 0·780·013treatment (se v. placebo)2270·390·15, 1·060·0662170·350·11, 1·080·0672100·300·09, 1·000·049age (years)2270·990·88, 1·100·818na§na§history of pe in mother2270·670·08, 5·380·710na§na§history of pe in sister2271·760·20, 15·420·608na§na§whole-blood se, 12 weeks (μmol/l)2270·810·13, 5·000·816na§na§whole-blood se, 35 weeks (μmol/l)2150·390·13, 1·220·106na§na§sepp1, 35 weeks (mg/l)2150·720·51, 1·010·060na§na§bp, blood pressure; na, not applicable; sepp1, selenoprotein p.*risk factors for the development of pe/pih assessed individually by logistic regression.†optimal model of risk factors for the development of pe/pih assessed by forward logistic regression, including diastolic bp, bmi, toenail se concentration and treatment.‡optimal model of risk factors for the development of pe/pih as in model 1, but excluding those se-treated women who took < 60 % of their treatment pills.§variable was not selected in the stepwise analysis.∥variable multiplied by 10 for scaling purposes. |
PubMedID- 24643210 | Severe hypertension, a feature of severe pre-eclampsia and preexisting hypertension [19, 20], and advanced maternal age [24] are associated with adverse neonatal outcomes because these mothers are prone to abruptio placenta, preterm delivery and neonatal deaths. |
PubMedID- 20513456 | The non-treated pathology is associated with higher risk of maternal morbidity, including arterial hypertension, which could lead to preeclampsia or eclampsia, ideation and suicide attempts, and postpartum depression. |
PubMedID- 26431848 | Worldwide, 10 % of all pregnancies are complicated by hypertension, with pre-eclampsia and eclampsia being the major causes of maternal and prenatal morbidity and mortality [1]. |
PubMedID- 20074343 | Beyond the hypertension, the discovery of secreted nkb during pre-eclampsia has led other researchers to investigate some of the other associated symptoms of pre-eclampsia. |
PubMedID- 22567524 | Compared to kidney transplant recipients, spkt recipients have similar rates of spontaneous miscarriage and therapeutic abortion, but higher rates of preterm delivery, low birth weight, hypertension, infection, pre-eclampsia, acute rejection, and graft loss in later years [14]. |
PubMedID- 22995748 | Given its potent vasoactive function and the prevalence of hypertension in pre-eclampsia, there has been extensive research on the role of et-1 in this disorder. |
PubMedID- 25076073 | Direct obstetric causes were dominant (90.6%), mainly hypertension (34.6%), with emphasis on eclampsia (70%), and hemorrhage (22.2%). |
PubMedID- 25512224 | hypertension in labor due to pre-eclampsia increased the amplitude of synergistic elevation of cerebral tissue hemoglobin caused by cyclic labor and intra-abdominal pressure. |
PubMedID- 22223909 | In our patient also, the hypertension was attributed to pre-eclampsia in her earlier antenatal visits, precluding preoperative optimisation with adrenergic blockade, and she was started on methyldopa and nifedipine. |
PubMedID- 22435711 | Conclusions: women who use antidepressants during pregnancy are at increased risk of pregnancy-induced hypertension with or without pre-eclampsia above and beyond the risk that could be attributed to their depression or anxiety disorders. |
PubMedID- 21207238 | The authors in this study assessed that partial or asymmetric pres was most commonly recognized in patients who have had organ transplantation and eclampsia with severe hypertension or normal blood pressure. |
PubMedID- 23118594 | There is a higher risk of maternal morbidity, including arterial hypertension leading to preeclampsia or eclampsia, suicide attempts and post partum depression. |
PubMedID- 22666812 | Risk factors for preterm birth were: previous history of preterm birth (or = 2.32; 95%ci: 1.25-4.29), maternal age (or = 2.00; 95%ci: 1.00-4.03), inadequate prenatal care (or = 2.15; 95%ci: 1.40-3.27), inadequate maternal weight gain (or = 2.33; 95%ci: 1.45-3.75), maternal physical injury (or = 2.10; 95%ci: 1.22-3.60), hypertension with eclampsia (or = 17.08; 95%ci: 3.67-79.43) and without eclampsia (or = 6.42; 95%ci: 3.50-11.76), hospitalization (or = 5.64; 95%ci: 3.47-9.15), altered amniotic fluid volume (or = 2.28; 95%ci: 1.32-3.95), vaginal bleeding (or = 1.54; 95%ci: 1.01-2.34), and multiple gestation (or = 22.65; 95%ci: 6.22-82.46). |
PubMedID- 24735917 | The relative risk of superimposed pre-eclampsia in women with chronic hypertension was on average across study populations nearly eightfold higher than was pre-eclampsia in the general pregnancy population, and all adverse neonatal outcomes were at least twice as likely to occur compared with the general population. |
Page: 1